Dual target blockade may be better than one in SLE Inhibition of B-cell Activating Factor (BAFF) has revolutionised th
Tweet Content
Dual target blockade may be better than one in SLE
Inhibition of B-cell Activating Factor (BAFF) has revolutionised the treatment of patients with systemic lupus erythematosus (SLE).
https://t.co/uu6ygb4l8B https://t.co/nLO3oSiEVa
Links
Show on Archive Page
On
Display in Search Results
On
PDQ
Off